Short-hairpin-RNA-mediated silencing of fucosyltransferase 8 in Chinese-hamster ovary cells for the production of antibodies with enhanced antibody immune effector function

被引:19
作者
Beuger, Vincent [1 ]
Kuenkele, Klaus-Peter [1 ]
Koll, Hans [1 ]
Gaertner, Achim [1 ]
Baehner, Monika [1 ]
Burtscher, Helmut [1 ]
Klein, Christian [1 ]
机构
[1] Roche Diagnost GmbH, D-82372 Penzberg, Germany
关键词
antibody; Chinese-hamster ovary cells (CHO cells); ESI-MS; electrospray-ionization MS; fucosyltransferase 8 (Fut8); gene silencing; immune effector function; short-hairpin RNA (shRNA); FC-GAMMA-RIIIA; NONFUCOSYLATED THERAPEUTIC ANTIBODIES; DEPENDENT CELLULAR CYTOTOXICITY; ANTI-CD20; MONOCLONAL-ANTIBODY; MANNOSE 4,6-DEHYDRATASE GMD; HUMAN IGG1; MAMMALIAN-CELLS; GLYCOFORMS; RECEPTORS; BINDING;
D O I
10.1042/BA20080220
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antibody-producing Chinese-hamster ovary cells (CHO-DG44) were converted into cells producing antibodies with strongly enhanced ADCC (antibody-dependent cellular cytotoxicity) by knocking down FuT8 (alpha-1,6-fucosyltransferase or fucosyltransferase 8) via constitutive expression of shRNA (short-hairpin RNA) against FuT8. After the introduction of a FuT8 shRNA expression plasmid under the control of a U6 promoter, CHO-DG44 clones with less than 5% residual FuT8 mRNA expression were isolated by selection for neomycin resistance, followed by low affinity nerve growth factor receptor enrichment and selection for LCA [Lens culinaris (culinary lentil) agglutinin] resistance. The CHO-DG44 clones identified produced highly afucosylated anti-[IGF-IR (insulin-like-growth-factor-I receptor)] antibodies (up to 88%) that exhibited considerably enhanced ADCC compared with anti-IGF-IR wild-type antibodies produced by parental CHO cells. At the same time, antibody productivity was not significantly decreased. Analysis of stability showed that the clones obtained may be suitable for up-scaling, since low residual levels of FuT8 mRNA and production of afucosylated antibodies were maintained for at least 4 weeks.
引用
收藏
页码:31 / 37
页数:7
相关论文
共 28 条
[1]   Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab [J].
Bowles, Julie A. ;
Wang, Siao-Yi ;
Link, Brian K. ;
Allan, Barrett ;
Beuerlein, Gregory ;
Campbell, Mary-Ann ;
Marquis, David ;
Ondek, Brian ;
Wooldridge, James E. ;
Smith, Brian J. ;
Breitmeyer, James B. ;
Weiner, George J. .
BLOOD, 2006, 108 (08) :2648-2654
[2]   A system for stable expression of short interfering RNAs in mammalian cells [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
SCIENCE, 2002, 296 (5567) :550-553
[3]   From the bench to the bedside: ways to improve rituximab efficacy [J].
Cartron, G ;
Watier, H ;
Golay, J ;
Solal-Celigny, P .
BLOOD, 2004, 104 (09) :2635-2642
[4]   Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene [J].
Cartron, G ;
Dacheux, L ;
Salles, G ;
Solal-Celigny, P ;
Bardos, P ;
Colombat, P ;
Watier, H .
BLOOD, 2002, 99 (03) :754-758
[5]   Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets [J].
Clynes, RA ;
Towers, TL ;
Presta, LG ;
Ravetch, JV .
NATURE MEDICINE, 2000, 6 (04) :443-446
[6]   Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells [J].
Elbashir, SM ;
Harborth, J ;
Lendeckel, W ;
Yalcin, A ;
Weber, K ;
Tuschl, T .
NATURE, 2001, 411 (6836) :494-498
[7]   The carbohydrate at FcγRIIIa Asn-162 -: an element required for high affinity binding to non-fucosylated IgG glycoforms [J].
Ferrara, C ;
Stuart, F ;
Sondermann, P ;
Brükner, P ;
Umaña, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (08) :5032-5036
[8]   Modulation of therapeutic antibody effector functions by glycosylation engineering:: Influence of Golgi enzyme localization domain and co-expression of heterologous β1,4-N-acetylglucosaminyltransferase III and Golgi α-mannosidase II [J].
Ferrara, C ;
Brünker, P ;
Suter, T ;
Moser, S ;
Püntener, U ;
Umaña, P .
BIOTECHNOLOGY AND BIOENGINEERING, 2006, 93 (05) :851-861
[9]   Double knockdown of α1,6-fucosyltransferase (FUT8) and GDP-mannose 4,6-dehydratase (GMD) in antibody-producing cells:: a new strategy for generating fully non-fucosylated therapeutic antibodies with enhanced ADCC [J].
Imai-Nishiya, Harue ;
Mori, Katsuhiro ;
Inoue, Miho ;
Wakitani, Masako ;
Iida, Shigeru ;
Shitara, Kenya ;
Satoh, Mitsuo .
BMC BIOTECHNOLOGY, 2007, 7 (1)
[10]   Comparison of cell lines for stable production of fucose-negative antibodies with enhanced ADCC [J].
Kanda, Yutaka ;
Yamane-Ohnuki, Naoko ;
Sakai, Naoto ;
Yamano, Kazuya ;
Nakano, Ryosuke ;
Inoue, Miho ;
Misaka, Hirofurni ;
Iida, Shigeru ;
Wakitani, Masako ;
Konno, Yoshinobu ;
Yano, Keiichi ;
Shitara, Kenya ;
Hosoi, Shinji ;
Satoh, Mitsuo .
BIOTECHNOLOGY AND BIOENGINEERING, 2006, 94 (04) :680-688